Iyona Rajkomar


Iyona joined Advent in 2015, bringing medical, public equity analysis, and consulting experience. She previously spent three years as a strategy consultant at PWC where her work involved corporate strategy, deal diligence and asset valuation in the pharma/biotech sector. Prior to that Iyona was an equity analyst for UBS and Bryan Garnier covering the European pharma and biotech space.

Iyona qualified as a medical doctor with Honours from St George’s Medical School and achieved the CFA charter in 2013.

Iyona has been involved in founding Aleta Biotherapeutics and Itara Therapeutics and is a Board Observer on both companies.

View Iyona's profile on LinkedIn


Assistant: Amber Rosamond
E: This email address is being protected from spambots. You need JavaScript enabled to view it.
T: +44 (0)20 7932 2157